Cargando…
Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus
Type 1 diabetes mellitus (T1DM) is caused by the autoimmune targeting of pancreatic β-cells, and, in the advanced stage, severe hypoinsulinemia due to islet destruction. In patients with T1DM, continuous exogenous insulin therapy cannot be avoided. However, an insufficient dose of insulin easily ind...
Autores principales: | Takahashi, Hiroyuki, Sakata, Naoaki, Yoshimatsu, Gumpei, Hasegawa, Suguru, Kodama, Shohta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406504/ https://www.ncbi.nlm.nih.gov/pubmed/30781427 http://dx.doi.org/10.3390/jcm8020249 |
Ejemplares similares
-
The Spleen as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem Cells
por: Sakata, Naoaki, et al.
Publicado: (2018) -
Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death
por: Matsuoka, Taisuke, et al.
Publicado: (2020) -
Development and Characteristics of Pancreatic Epsilon Cells
por: Sakata, Naoaki, et al.
Publicado: (2019) -
Possibility of adiponectin use to improve islet transplantation outcomes
por: Sakata, Naoaki, et al.
Publicado: (2022) -
Therapeutic effects of acylated ghrelin-specific receptor GHS-R1a antagonist in islet transplantation
por: Chinen, Kiyoshi, et al.
Publicado: (2021)